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Abstract
Purpose of review: Functional movement disorders
(FMD) are commonly seen in neurologic practice,
but are associated with poor outcomes. Recent years
have seen a resurgence of interest in this area, with
new developments in pathophysiologic understand-
ing and therapeutic management. Recent findings:
Individuals with FMD are a psychologically heteroge-
neous group, with many individuals having no detect-
able psychopathology on symptom screening
measures, and possibly significant etiologically rele-
vant life events only revealed through in-depth inter-
views. A randomized trial of specialist intensive
physical rehabilitation compared to community-
based neurophysiotherapy in FMD has demon-
strated moderate to large effect sizes for both physical and social functioning outcomes.
Experimental evidence suggests an impairment in the neural systems conferring a sense
of agency over movement in individuals with FMD, and may explain why movements that ap-
pear voluntary are not experienced as such. Summary: The prognosis of individuals with
FMD may be improved with greater access to appropriately organized care and
treatment. Neurol Clin Pract 2017;7:1–7
Functional movement disorders (FMD) are abnormalities of movement that are alteredby distraction or nonphysiologic maneuvers, and are clinically incompatible withmovement disorders associated with neurologic disease. FMD are a common presen-tation of the wider category of functional neurologic disorder. Functional disorders
are extremely common in neurologic practice, with one study demonstrating that functional
neurologic disorder accounted for 15% of new referrals seen in neurology clinics, second only
to headache.1 Despite their common occurrence, prognosis is poor, with a systematic review
finding that 39% of patients were the same or worse on long-term follow-up, with high levels
of physical disability and psychological comorbidity.2 Individuals diagnosed with FMD have
traditionally been left in a therapeutic wasteland, with neither neurologist nor psychiatrist able
to provide strategies to bring about symptom resolution.
There have been a number of recent advances in the field of FMD, including not only
a rebranding of its name, but a deeper understanding of pathophysiologic aspects of the con-
dition, and most importantly, a pathway to successful treatment. We highlight here some rays
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of light in a dark landscape, providing a sense of optimism to an area long equated with frus-
tration for both patients and their care providers.
What’s in a name?
There has been recent debate in the literature with respect to the term psychogenic movement
disorders, with a broader term, functional movement disorders, suggested to take its place.3,4
The main argument for this rebranding is that the term psychogenic implies that the etiology
of the symptoms is understood as being born of the mind. However, diagnosis is made with
reference to positive symptoms and signs and not on the presence of psychopathology. A
psychological trigger is not possible to establish in many patients, though it is difficult to be
sure if this is because it is not present or simply not recognized. The term functional has been
proposed as being freer from etiologic assumptions and recognizes that the cause of these
symptoms may not be evident. Functional is the second most common term used between
colleagues specializing in movement disorders, and is a term used without controversy in
other areas of medicine.3 Importantly, publication of the DSM-5 brought about changes to
the criteria for conversion disorder, including its name, which now includes functional
neurologic symptom disorder in parentheses. The DSM-5 criteria have also been modified
to emphasize the importance of the neurologic examination, and that relevant psychological
factors may not be present. Specifically, clinical findings should provide evidence of incom-
patibility between the symptom and a recognized neurologic condition.
Psychological factors
Researchers continue to explore the psychological underpinnings of FMD, with recent studies
seeking to confirm the Freudian hypothesis of conversion, and conversely, to validate the re-
moval of criteria for psychological stressors from DSM-5. A case-control study of 51 individuals
with FMD evaluated self-rated measures of depression, anxiety, dissociation, and personality
disorders compared to individuals with neurologic (organic) movement disorders and healthy
controls.5 Thirty-nine percent of individuals with FMD scored in the normal range on all
psychological questionnaires, compared to 38% of individuals with neurologic movement
disorders and 89% of controls. Patients with FMDs had similar scores as patients with
neurologic movement disorders for symptoms of depression, anxiety, and psychological dis-
sociative symptoms, and only differed on symptoms of somatic dissociative symptoms. The
study concluded that individuals with FMD are not different psychologically from individuals
with neurologic movement disorders, and that a relevant proportion of individuals with FMD
have no psychopathology detectable on symptom screening measures.
Using the Life Events and Difficulties Schedule, Nicholson et al.6 evaluated severe life
events (life events associated with a long-term marked or moderate threat) and escape events
(the extent to which the effect of a stressor might be ameliorated by being ill with neurologic
symptoms) in the year preceding symptom onset in 43 individuals with motor conversion
disorder (motor symptoms thought to be psychological in origin), 28 individuals with de-
pression, and 28 healthy controls. Fifty-six percent of individuals with conversion disorder
had at least one severe event in the month before symptom onset, significantly more com-
pared to 21% of individuals with depression (odds ratio [OR] 4.63) and 18% of healthy
controls (OR 5.81). Fifty-three percent of patients with conversion disorder had a least one
high escape event, which was significantly higher than in those with depression (14%) and
healthy controls (0%). The majority of etiologically relevant life events were not detected on
routine assessment, suggesting that in-depth and specific interviewing skills are necessary to
reveal these events. Whether these life events represent transient triggers or important main-
taining factors in symptoms (and therefore of treatment relevance) remains uncertain.
Overall, these findings point to the heterogeneous psychological background to patients
with FMD. A simplistic approach to diagnostic explanation and treatment (“this has happened
because of stress, you need to see a psychologist”) fails to acknowledge this complexity. A
sensitive and open-minded exploration of psychological factors potentially conferring
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vulnerability to develop FMD and maintenance of symptoms is useful and should be part of
an individualized approach to diagnostic explanation and treatment. This exploration may
well find no relevant factors, or find factors that have conferred vulnerability but are not
currently active, and explanation of diagnosis and treatment needs to have the flexibility to
accommodate these common situations.
Loss of sensory attenuation
A major issue in attitudes towards patients with FMD is a doubt as to whether the symptoms
might be voluntarily, deliberately produced. After all, the movements seen in many people with
FMD have characteristics associated with voluntary movement, for example distractibility. If
patients are by and large telling the truth, then one explanation could be that the system that
confers sense of agency over movement is impaired in patients with FMD. There are other sit-
uations in neurology and psychiatry where movements that appear voluntary are not experi-
enced as such, for example alien limb and anarchic hand syndromes and delusions of
control in schizophrenia. Disordered function of systems conferring sense of agency for move-
ment are commonly suggested to explain such phenomena. Sensory attenuation is a phenom-
enon whereby the intensity of sensation caused by self-generated movements is reduced.
Sensory attenuation is believed to be important in labeling movements as self-generated, and
a loss of sensory attenuation has been associated with a loss of agency for movement,7 and
has previously been reported to be abnormal in patients with schizophrenia with delusions of
control.8 An investigation of sensory attenuation in individuals with FMD was recently
performed using a force matching paradigm.9
In the force matching paradigm, participants are asked to match a force delivered to the
finger by pressing directly onto the finger with the other hand (the self condition), or by
operating a joystick that causes a robot to press down on the finger (the external condition).
Healthy participants consistently generate more force than necessary during the self
condition—due to the phenomenon of sensory attenuation—compared with the external
condition. Individuals with FMD are much more accurate than healthy controls in their
force estimation performance in the self condition. Performance between the 2 groups
did not differ for the external condition. This difference in performance between the 2
groups is thought to be due to a loss of sensory attenuation in individuals with FMD,
which may reflect a lack of agency for self-generated movements. The authors propose
that a generalized increase in body-focused attention in patients with FMD means that
they do not attenuate the sensory consequences of their actions, and that this makes them
more likely to lose sense of agency for their actions.
Neuroimaging
Previous functional imaging studies in patients with FMD have found evidence for temporo-
parietal junction hypofunction—this area is thought to be important in comparing
actual with expected sensory feedback during movement, and hence in sense of agency for
movement. Abnormal connectivity between motor and limbic areas has also been
demonstrated.10,11
Researchers have attempted to examine the neural correlates of recall of life events judged to
be of causal significance in individuals with conversion disorder, following the Freudian
A major issue in attitudes towards patients
with FMD is a doubt as to whether the
symptoms might be voluntarily, deliberately
produced.
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hypothesis of repression of psychological conflict and conversion of symptoms to physical dis-
ability in individuals with functional disorders.12 Using the Life Events and Difficulties
Schedule to identify severe life events and escape events (as described above) in 12 indi-
viduals with conversion disorder and 13 controls, the researchers obtained details about
severe life events, escape events, and a neutral event from the same time period to generate
72 statements. Twenty-five percent of the statements were made incorrect by changing
details, to maximize immersive recall when later asked in the fMRI setting if statements
were true or false. Blocks of 8 statements were presented in random order by condition
(severe, escape, neutral), for which participants had to respond if each statement was true or
false. Reaction times for true or false responses were recorded, and participants were asked
to rate how upsetting the block of statements was using a visual analogue scale. Functional
MRI during recall of the escape condition relative to the severe condition in patients vs
controls revealed increased activity in the left dorsolateral prefrontal cortex, with decreased
hippocampal and parahippocampal activity, a pattern compatible with memory suppression.
Escape events also elicited significantly longer reaction times than neutral events and were
perceived as less upsetting than severe events, though they were matched in threat level.
These changes were accompanied by an increase in activity in the right supplementary
motor cortex and right temporal parietal junction, areas involved in motor execution and
sensory integration.
Overall these studies help to establish the underlying neural correlates of FMD, as well as the
way in which etiologic factors, such as life events, might influence the underlying neurobiology
of the disorder.
Therapeutic advance: Specialist physiotherapy
Nielsen et al.13 described a pilot 5-day specialist physiotherapy program for individuals with
FMD, focusing on education, movement retraining, and long-term self-management. As
a foundation, a pathophysiologic model of FMD was presented and taught to participants
(figure). Patients engaged in a collaborative discussion of how their symptoms started and
progressed, considering both physical and psychological triggers, as well as factors that may
have perpetuated symptoms. Mirrors and video recordings were used to help explore move-
ments and identify strategies to normalize movement patterns. Patients were guided by
a physiotherapist to use these strategies in progressively more difficult tasks. This program
was subsequently compared to treatment as usual (community-based neurophysiotherapy) in
a randomized feasibility trial.14 Sixty participants were randomly allocated to the 5-day
specialist program or to referral to a local physiotherapy service. At 6 months follow-up,
individuals allocated to the specialist program had superior scores compared to the control
group in the Physical Function, Physical Role, and Social Function domains of the Short
Form–36, the Berg Balance Scale, the 10-meter walk time, the Functional Mobility Scale, the
Disabilities of the Arm Shoulder and Hand scale, and the Brief Illness Perception Question-
naire, with medium to large effect sizes (d 5 0.46–0.79). Seventy-two percent of those
receiving the specialist program reported a good outcome, compared to 18% in the control
group. Measures of mental health did not change in either group, suggesting that physical
function can be improved in individuals with FMD without changes in mental health
symptoms.
This study adds to previous work in indicating that specialist physical rehabilitation can
be helpful in some patients with FMD. Consensus guidelines support this approach,15 and
emphasize the need for good diagnostic explanation and patient selection in ensuring
good outcome. Patients with active untreated psychopathology or with severe pain and
fatigue as dominant symptoms may be less suitable for this high-intensity treatment. It is
notable that most patients included in published studies of specialist physiotherapy for
FMD had already received physiotherapy previously, often on multiple occasions, with-
out benefit. This argues against a simple face-saving explanation for the benefit of
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physiotherapy (i.e., that getting better with a physical intervention is more socially/
personally acceptable than improvement with a psychological intervention) and instead
suggests that there are specific physical rehabilitation techniques that are useful in this
patient group.
DISCUSSION
This selection of recent work in patients with FMD is part of a wider development of scientific
and clinical interest in patients with functional neurologic symptoms in general. This is to some
Figure Triggering events
[T]he neurologist is ideally placed to coordinate
care and to take on long-term follow-up of
patients with functional neurologic disorder.
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extent a redevelopment of interest in what was a major topic of
neuroscientific interest in the mid to late 19th century. Under-
pinning it all is a large group of patients with neurologic symp-
toms, often disabling and impairing to quality of life, who lack
access to organized care and treatment.
The work presented here emphasizes that it is the neurologist
who should take on the responsibility for caring for patients with
functional neurologic disorder, including FMD. These patients
present with neurologic symptoms, the diagnosis is made on
the basis of positive symptoms and signs by a neurologist, and
the patient expects a diagnostic explanation from the neurologist.
Given this, the neurologist is ideally placed to coordinate care
and to take on long-term follow-up of patients with functional
neurologic disorder. As with many other common neurologic
conditions, treatment may involve other professionals, including
mental health professionals, but the neurologist can have an im-
portant coordinating role.
The hope is that renewed interest in FMD and its treatment
reviewed here will bring with it a new evidence base for manage-
ment. There might therefore be hope for a better future for patients
and their families with this important cause of neurologic disability.
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• Preferential use of the term functional
movement disorders is proposed as being
freer from etiologic assumptions and
recognizes that the cause of symptoms
may not be evident.
• Patients with functional movement
disorders have heterogeneous
psychological backgrounds.
• Specific physical rehabilitation techniques
can be helpful in improving physical and
social function in individuals with functional
movement disorders.
• Experimental evidence suggests that
individuals with functional movement
disorders do not attenuate the sensory
consequences of their actions, and that this
may reflect their lack of sense of agency for
their actions.
• Functional MRI during recall of life events
judged to be of causal significance in
individuals with conversion disorder reveals
increased activity in the left dorsolateral
prefrontal cortex, with decreased
hippocampal and parahippocampal activity,
a pattern compatible with memory
suppression.
6 © 2017 American Academy of Neurology
Tamara Pringsheim and Mark Edwards
ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
15. Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus
recommendation. J Neurol Neurosurg Psychiatry 2015;86:1113–1119.
Received October 27, 2016. Accepted in final form January 23, 2017.
AUTHOR CONTRIBUTIONS
Tamara Pringsheim wrote the first draft of the manuscript. Mark Edwards edited and revised the
manuscript.
STUDY FUNDING
No targeted funding reported.
DISCLOSURES
T. Pringsheim serves on the Editorial Boards of Neurology: Clinical Practice and Canadian Journal of
Psychiatry and receives research support from Canadian Institutes of Health Research, Sick Kids
Foundation, and Alberta Mental Health Strategic Clinical Network. M. Edwards serves on scientific
advisory boards for Cure Parkinson’s Trust, UK Dystonia Society, and Medical Research Council; has
received funding for travel and accommodation from the Movement Disorder Society and Merz
Pharma; receives publishing royalties for Oxford Specialist Handbook of Parkinson’s Disease and Move-
ment Disorders (Oxford University Press, 2008); and receives research support from Medical Research
Council NIHR (UK) and Parkinson’s UK Dystonia Society. Full disclosure form information provided
by the authors is available with the full text of this article at Neurology.org/cp.
Related articles from AAN physician and patient resources
Neurologyw Clinical Practice
Psychogenic nonepileptic seizures and movement disorders: A comparative review
April 2016;6:138–149.
Neurologyw C Neurology.org
Clinical decision-making in functional and hyperkinetic movement disorders
January 10, 2017;88:118–123.
New insights into the neural basis of functional movement disorders
August 9, 2016;87:554–555.
Continuumw C ContinuumJournal.com
Functional Neurologic Disorders
June 2015;21:818–837.
Neurology Todayw C Neurotodayonline.com
How to Diagnose Functional Movement Disorders? First Impressions of Patients Play a Major
Role, Surveyed Experts Reveal
December 22, 2016;16:24–26.
Neurology: Clinical Practice ||| April 2017 Neurology.org/cp 7
Functional movement disorders
ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
DOI 10.1212/CPJ.0000000000000350
 published online March 24, 2017Neurol Clin Pract 
Tamara Pringsheim and Mark Edwards
Functional movement disorders: Five new things
This information is current as of March 24, 2017
Services
Updated Information &
 50.full.html
http://cp.neurology.org/content/early/2017/03/24/CPJ.00000000000003
including high resolution figures, can be found at:
Subspecialty Collections
 http://cp.neurology.org//cgi/collection/motor_control
Motor Control
 http://cp.neurology.org//cgi/collection/conversion
Conversion
 http://cp.neurology.org//cgi/collection/all_rehabilitation
All Rehabilitation
 http://cp.neurology.org//cgi/collection/all_movement_disorders
All Movement Disorders
following collection(s): 
This article, along with others on similar topics, appears in the
  
Permissions & Licensing
 http://cp.neurology.org/misc/about.xhtml#permissions
its entirety can be found online at:
Information about reproducing this article in parts (figures,tables) or in
  
Reprints
 http://cp.neurology.org/misc/addir.xhtml#reprintsus
Information about ordering reprints can be found online:
Neurology. All rights reserved. Print ISSN: 2163-0402. Online ISSN: 2163-0933.
since 2011, it is now a bimonthly with 6 issues per year. Copyright © 2017 American Academy of 
is an official journal of the American Academy of Neurology. Published continuouslyNeurol Clin Pract 
